Results 191 to 200 of about 173,104 (214)

Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease

Nature reviews: Gastroenterology & hepatology, 2023
Gong Feng, L. Valenti, V. W. Wong, Yasser M Fouad, Yusuf Yilmaz, Won Kim, G. Sebastiani, Z. Younossi, V. Hernández-Gea, M. Zheng   +9 more
semanticscholar   +1 more source

The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease

Nature reviews: Gastroenterology & hepatology, 2023
L. Díaz, J. Arab, A. Louvet, R. Bataller, M. Arrese   +4 more
semanticscholar   +1 more source

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Hepatology, 2005
D. Kleiner, E. Brunt, M. V. Van Natta, Cynthia Behling, M. Contos, O. Cummings, L. Ferrell, Yao‐Chang Liu, M. Torbenson, A. Unalp-arida, M. Yeh, A. McCullough, A. Sanyal   +12 more
semanticscholar   +1 more source

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel   +2 more
exaly  

Cancer statistics, 2023

Ca-A Cancer Journal for Clinicians, 2023
Rebecca L Siegel, Kimberly D Miller, Nikita Sandeep Wagle   +2 more
exaly  

Microbiome-derived ethanol in nonalcoholic fatty liver disease

Nature Network Boston, 2022
A. Meijnikman, M. Davids, H. Herrema, O. Aydin, V. Tremaroli, Melany Rios-Morales, H. Levels, S. Bruin, M. D. de Brauw, J. Verheij, Marleen Kemper, A. Holleboom, M. Tushuizen, T. W. Schwartz, J. Nielsen, D. Brandjes, E. Dirinck, J. Weyler, A. Verrijken, Christophe de Block, L. Vonghia, S. Francque, U. Beuers, Victor E. A. Gerdes, F. Bäckhed, A. Groen, M. Nieuwdorp   +26 more
semanticscholar   +1 more source

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Jingxuan Zhao, Xuesong Han, Leticia M Nogueira   +2 more
exaly  

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

Ca-A Cancer Journal for Clinicians, 2023
Demetrios Moris
exaly  

The gut–liver axis and gut microbiota in health and liver disease

Nature Reviews Microbiology, 2023
Cynthia Li-Shin Hsu, Bernd Schnabl
exaly  

Immunotherapies for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2021
, Florian Castet, Mala K Maini
exaly